OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

Charity registration number 1107496

ARRHYTHMIA ALLIANCE

ANNUAL REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

ARRHYTHMIA ALLIANCE

LEGAL AND ADMINISTRATIVE INFORMATION

Trustees Mrs T C A Lobban MBE
Mr N Breakwell
Professor N J Linker
Prof. A J Camm
Mr P Turner
Mr P Chauvineau
Mr M Bullock
Dr A J Turley
Professor. J Morgan (Appointed 12 August 2025)
Charity number 1107496
Principal address TC Group
Celixir House
Stratford Business & Technology Park
Stratford - upon - Avon
Warwickshire
CV37 7GZ
Auditor Bronsens
Chartered Certified Accountants
Eden House
Two Rivers Business Park
Station Lane
Witney
OX28 4BL

ARRHYTHMIA ALLIANCE

CONTENTS

Page
Trustees report 1 - 10
Statement of Trustees responsibilities 11
Independent auditor's report 12 - 14
Statement of financial activities 15
Balance sheet 16
Statement of cash flows 17
Notes to the financial statements 18 - 27

ARRHYTHMIA ALLIANCE

TRUSTEES REPORT

FOR THE YEAR ENDED 31 DECEMBER 2025

The Trustees present their annual report and financial statements for the year ended 31 December 2025.

The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the charity's Trust deed the Charities Act 2011 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019).

Objectives and activities

Principal objectives

The principal objectives of the charity are:

To advance education into the causes, prevention, diagnosis and treatment of cardiac arrhythmias and promote a better understanding, awareness and quality of life for those affected by cardiac arrhythmias. There have been no changes to these objectives in the period of review.

Objectives for the year

To raise awareness of cardiac arrhythmias To improve diagnosis of cardiac arrhythmias To improve treatment of cardiac arrhythmias To improve quality of life for people living with cardiac arrhythmias

To lead the development of professional standards and hold them in trust on behalf of the sector, both nationally and internationally

To build and maintain a national network of organisations and individuals committed to achieving best practice in service delivery

Strategies

To bring together member charities, healthcare professionals, commissioners and their allies To advance the concerns and needs of all our members

To develop the knowledge and skills base of medical professional and professions allied to medicine To cultivate multi-centre and multi-disciplinary research

To prevent sudden cardiac death in vulnerable groups

To promote the value and need for cardiac pacing, implantable defibrillators, catheter ablation and other treatments for cardiac arrhythmia

To prevent misdiagnosis in patients suffering from arrhythmia and transient loss of consciousness (T-LOC) To assess and quantify unmet need amongst those affected by cardiac arrhythmia

To promote centres of excellence for arrhythmia diagnosis and treatment

To secure better care, leading to a better quality of life, for individuals with cardiac arrhythmia

Public benefit

The Trustees have paid due regard to guidance issued by the Charity Commission in deciding what activities the charity should undertake. The Trustees confirm that they have complied with their duty under Section 4 of the Charities Act 2011 to have due regard to the Charity Commission's general guidance on public benefit.

Volunteers

Arrhythmia Alliance utilises volunteers to assist in our work.

ARRHYTHMIA ALLIANCE

TRUSTEES REPORT (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

Achievements and performance

Arrhythmia Alliance is a coalition of patients, carers, healthcare professionals, policy makers, allied professionals and all those affected by or involved in the care of cardiac arrhythmias. Arrhythmia Alliance (A-A) was established in 2004 after the successful campaign led by STARS (Syncope Trust and Reflex Anoxic Seizures) charity to introduce a new chapter into the National Service Framework for Coronary Heart Disease on Arrythmias and Sudden Cardiac Death (Chapter 8). At that time there were only 60 electrophysiologists in the UK and yet two million people known to be suffering with various arrhythmias. There was no agenda for atrial fibrillation at that time despite it being the most common arrhythmia. Trudie Lobban MBE, Founder and Trustee, was the first non-medical person to be invited to join the expert writing group for the chapter by the Department of Health and Prof. Roger Boyle, the then National Clinical Director for Heart Disease.

A-A is recognised globally with representation in over 40 countries, and hosts World Heart Rhythm Week in June each year and the International Heart Rhythm Congress. A-A provides information, support, education, and awareness of all heart rhythm disorders.

This report covers the following areas:

  1. Supporting people living with a heart rhythm condition

  2. Raising awareness of arrhythmias

  3. Fundraising

  4. Grants

  5. Hosting educational events for both healthcare professionals and patients

  6. Voluntary and affiliated groups

  7. Prominent activities 8. Staff

1. Supporting Patients

European Patient Advocacy Toolkit

Our European Patient Advocacy Toolkit which was launched in 2024 continues to enable patients to share valuable information for others to understand the journey from symptoms to diagnosis, to treatment by becoming an advocate. Around 620 million people are living with heart and circulatory diseases across the world.

We invite patients to give their insights and experience to help those who may be struggling to be seen and have their condition detected, to be protected and finally have it corrected and access to treatment. The toolkit empowers patients to advocate for themselves, share their own story and support others who are newly diagnosed. The patient voice is vital to not only other patients, but to healthcare professionals, industry partners and decision makers. Patients are the experts on living with their condition, and their voice should be considered when making decision of care. We want to make sure that no person with CVD (cardiovascular disease) must live with pain or disability because they were not diagnosed early enough, did not receive the right treatment, or were not given the support they needed.

Patient Advocacy Training

The UK is receiving good uptake in our training programme, Patient Advocacy - Arrhythmia Alliance - UK and upon completion of the training our Patient Services Team provide an overview of how they can become involved in research studies, surveys, patient stories and hosting KYP events.

ARRHYTHMIA ALLIANCE

TRUSTEES REPORT (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

Resources

Our online and printed patient resources, reviewed by patients and caregiver volunteers and approved by our Medical Advisory Committee continue to be a valuable source of information. We have created and/or updated discussion guides and information booklets to enable people living with a condition to ask questions of their medical healthcare professional to assist towards a shared-decision and to ensure those living with the condition have the information and understanding of the signs, symptoms and potential treatment options. This is an ongoing project year on year as we review and update. New resources this year include Discussion Guides on ICD/ S-ICD and EV-ICD and a patients information sheet on an implantable cardioverter defibrillator (ICD). All resources received a complete medical review, this review consisted of Information Sheets, Booklets Posters and Discussions Guides totalling: 257 - https://heartrhythmalliance.org/aa/uk/resources/arrhythmia-alliance-patient-resources

We also provide monthly e-newsletters and news reviews E-newsletters - Arrhythmia Alliance - UK via email and are also available on our websites.

Living with Series – Patient Education

We continue to make available educational webinars ‘Living with…’ with subtitles. These webinars are free to register and provide up to date information covering devices, drugs, conditions, lifestyles and latest digital technologies and treatments presented by medical experts. They are promoted widely across Patient Day agendas and on our virtual Patients Stand. https://heartrhythmalliance.org/aa/uk/patients/living-with-series-educationalresources-and-videos

Campaigns

Know Your Pulse to Know Your Heart Rhythm – it could save your life

Know Your Pulse (KYP) campaign promotes the need to be aware of the rhythm of our heart. If pulse checks were routine, thousands of lives could be saved every year, through the prevention of AF-related strokes. Know Your Pulse - Arrhythmia Alliance - UK (heartrhythmalliance.org)

contains many new videos and informative educational materials.

Heart rhythm disorders are Britain’s number one killer; more than three million Britons are affected by an arrhythmia (irregular heart rhythm). Through a simple pulse check irregular heart rhythms can be detected and lives potentially saved. We held regional KYP events during 2025 and detected several with a potential irregular heart rhythm leading to diagnosis and preventative treatment. This educated, informed and raised awareness of the importance of knowing your pulse, the easiest way to detect an arrhythmia.

Defibs Saves Lives

Arrhythmia Alliance’s well-established programme, ‘Defibs Saves Lives’ Defibs Save Lives - Arrhythmia Alliance - UK (heartrhythmalliance.org) is an education-based advocacy campaign that serves communities all over the world, equipping them with the education, tools and resources necessary to implement the chain of survival during sudden cardiac arrest (SCA) events. Long standing campaigns all continue to attract attention in placing AED’s and through our work many communities now have a defibrillator accessible 24/7. Access to an AED should be within a 3-minute walk as every minute that passes after an SCA the chance of survival decreases by 10% so an AED needs to be used within the first few minutes.

ARRHYTHMIA ALLIANCE

TRUSTEES REPORT (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

Coffee Mornings

Arrhythmia Alliance virtual Coffee Mornings are hosted by our Patient Services Team providing support for the patient journey, understanding your condition, giving advice and information on varying heart rhythm disorders including inherited arrhythmias, device treatments and lifestyle advice. Also giving an opportunity for patients, caregivers and family members to share their experiences. During 2025 the Patient Service Team hosted 13 virtual coffee mornings, and they have grown in popularity due to the variety of topics covered and the attendance of HCPs.

Total attendees this year increased to 320.

2. Raising Awareness of Arrhythmias

Arrhythmia Alliance - World Heart Rhythm Week- 02-08 June 2025

World Heart Rhythm Week (WHRW) www.worldheartrhythmweek.org

is an annual awareness week where Arrhythmia Alliance and its sister charities, AF Association and STARS, ask supporters with an interest in arrhythmias and healthcare professionals working in the field, to help raise awareness of arrhythmias and related conditions.

During World Heart Rhythm Week 2025 thousands took to social media and communities helped spread awareness of the 2025 theme, ‘One Heart, Many Rhythms: Awareness, Action, Advocacy’ , which encouraged individuals to not only be aware of heart rhythm disorders but also act and advocate for themselves and those that are undiagnosed.

A-A World Heart Rhythm Week (WHRW) Palace of Westminster Reception was held in the Terrace Pavilion, Houses of Parliament, London. The event was attended by 122 delegates including three MPs. The event was hosted by Harpreet Uppal MP. Other MPs in attendance were Damian Hines MP and Josh Newbury MP. As part of the reception, we ran pulse checks to highlight our Know Your Pulse (KYP) programme promoting the need for us to be aware of our pulse and for the need to perform routine manual pulse checks. A total of 23 single-lead ECGs using the AliveCor Kardia Mobile app device were recorded. Two of the ECG’s showed a reading of ‘possible AF’ detected, and the individuals were provided with a referral letter and suggestion they should contact their GP for further investigation.

A-A WHRW social media campaign received over 170,000 impressions. Over 170 Resource Packs were ordered leading up to WHRW from hospitals and GP surgeries to disseminate to their patients. A-A SVT Awareness Day posts reached over 15,000 people and were shared over 170 times across our social media platforms. During the week, WHRW webpages were visited more than 2,500 times, and engaged with over 7,300 times.

ARRHYTHMIA ALLIANCE

TRUSTEES REPORT (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

Partnerships and Reciprocals

We have partnered this year with Heart Rhythm Society (HRS) and will now have a page on their web site - HRSonline.org and CardiQ and they will be posting in the HRS Membership news called “Keeping Pace” that Arrhythmia Alliance/AF Association and STARS are new partners and we have a page here https://cardiq.org/ - community partners/

Arrhythmia Alliance was invited, as part of the 2025 reciprocal agreement with European Heart Rhythm Association (EHRA) to have a complimentary booth at the EHRA 2025 conference in Vienna, Austria.

As part of the reciprocal agreement we have with EHRA, Arrhythmia Alliance promoted the event through the external events page on our website, on our social media accounts, and in our e-newsletter which is sent to our healthcare professional and medical industry audience.

Affiliates with A-A are EHRA, WSA, ESC, BCS, PCCS, HRS, FirstHearts Worldwide, AHA, ACC, BANCC, NICE,Dept of Health, NHS, ABHI, CRM, ABPI, touchCARDIO.

3. Fundraising

We are encouraged to see more fundraisers coming forward in 2025 through Just Giving raising a massive £15,590 in total over the year. In addition, one fundraiser who ran the London Marathon for the charity gained an incredible total of just over £10,000

4. Grants

We continue to apply for grants although it is proving a challenge as the economy is struggling following the covid years and therefore less money available through grants. £94,500

5. Supporting Healthcare Professionals

A-A Heart Rhythm Updates (HRU)

These events are designed to educate and share best practice regionally; they cover such topics as devices, drug treatments, atrial fibrillation and syncope.

Each meeting is designed to inform Healthcare Professionals (HCPs) who provide pivotal care, treatment, management and support to patients with arrhythmias. These include cardiac nurses, advanced nurse practitioners, physiologists, pharmacists, GPs and other allied health professionals.

There is also the opportunity for delegates, faculty and sponsors to interact and gain knowledge on the latest technologies, devices and medications and to learn more about the work of A-A.

The agenda covers a wide range of topics of interest, highlighting best practices and provides opportunities for delegates and faculty to share experiences and challenges within a local/regional educational environment. This year we arranged physical meetings around the UK in Liverpool, Durham Tees Valley, Oxford, London, Portsmouth and Birmingham, covering topics such as:

Leadless Cardiac Devices – What do they offer Screening & Prevention of AF Avoid AF-related Stroke with anticoagulation Who should undergo AV node ablation Conduction System Pacing - where are we now? New ablation techniques for AF Complex device pre-implant clinic

ARRHYTHMIA ALLIANCE

TRUSTEES REPORT (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

A-A Heart Rhythm Congress (HRC)

Heart Rhythm Congress (HRC) Home - HRC2025 - Heart Rhythm Congress is the flagship annual event of the charity, and 2025 marked a significant milestone—our 21st congress.

The inaugural HRC took place in 2005 at the Birmingham Motor Museum, later moving to the Birmingham Airport Hilton Hotel, and since 2012, has been held at the Birmingham International Convention Centre (ICC).

HRC is the largest event in the UK dedicated to heart rhythm disorders, drawing healthcare professionals and expert faculty from around the world. It offers a unique platform for sharing best practices, showcasing innovation, learning about the latest developments, and networking with both UK and international delegates. HRC was the first event of its kind to include a comprehensive Patient Day focused on arrhythmias, alongside educational sessions for nurses, primary care professionals, and those seeking specialist accreditation. A major trade exhibition runs alongside the event, all with the goal of improving patient outcomes by uniting multidisciplinary healthcare professionals.

This year, HRC took place from Sunday 5th to Tuesday 7th October 2025 at the ICC, Birmingham.

The congress welcomed 155 expert faculty members, including internationally renowned specialists. Additional sessions included EP Traces and the Paediatric Study Day. In total, 138 exhibitors participated, and 2050 delegates attended.

Healthcare professionals who attended HRC qualified for up to 24 Continuing Professional Development (CPD) points approved by the Royal College of Physicians.

Patients Day was held on Sunday 5th October 2025 at the ICC, Birmingham. This year, the focus was solely on the AF Association and STARS sessions. What makes HRC unique is its dedicated day for patients—aligning with the Arrhythmia Alliance’s mission to improve the timely and effective diagnosis and treatment of arrhythmias.

Patients Day offers a rare opportunity for medical professionals to engage directly with those living with arrhythmias, gaining insight into the challenges they face. It also gives patients and caregivers a supportive environment to share experiences with others in similar situations.

A total of 150 patients and caregivers attended.

A- A Pace4Life

In 2025 Arrhythmia Alliance Pace4Life (A-A P4L) Pace4Life - Arrhythmia Alliance - UK saw a large expansion of missions and resources. With the ability to support five missions to Nigeria, Kenya, Ghana and Syria Also provided an additional 100 devices to countries (Paraguay, Honduras, Mexico) who have an established pacing program. The year focused on developing improved procedures. Lessons learned throughout the year will shape how we operate missions in the future. Overall, it was a highly successful year.

A-A P4L joined the Global Cardiovascular Collaborative, a group of like-minded charities that all focus on building pacing programs throughout the globe. The collaborative provides a valuable forum to discuss the global pacing landscape and identify gaps where support is most needed. GCC meets monthly and connects on an ad-hoc basis otherwise.

Hearts of Ghana

During 2025 Hearts of Ghana Hearts of Ghana - Arrhythmia Alliance - UK supported two mission trips to Accra, Ghana to support the UGMC Heart Centre in support of advancing this important cardiovascular program.

Hearts of Ghana focused its priority during the two missions on highly complex cases, skill transfer and education. The teams also provided additional procedures and non-invasive testing for additional patients during the week.

FOR THE YEAR ENDED 31 DECEMBER 2025

ARRHYTHMIA ALLIANCE

TRUSTEES REPORT (CONTINUED)

On the first mission the local collaborative and Arrhythmia Alliance teams completed five complex and high-risk cardiovascular interventions, multiple evaluations and treatments, as well as ongoing multidisciplinary skill transfer and education.

The second mission included eight surgical cases and two additional procedures. For this mission, Hearts of Ghana included a thoracic surgeon to support thoracic cases and provide additional training to the UGMC team. The Hearts of Ghana educational programming during the second mission consisted of eight training sessions along with the hands-on training that occurred throughout the week. Education was a central focus of the mission.

5. Volunteers and Affiliated Groups

We continue to support affiliated groups and organisations and help to establish local support groups. Community support groups aim to provide both physical and emotional support to patients living with arrhythmias. Through our educational resources, community partners and heart health devices we can provide patients with the support that they need to live their best lives.

6. Prominent Activities

Trudie Lobban MBE, Founder and Trustee of Arrhythmia Alliance, continues to receive international recognition through invitations to present and participate at leading global events, including the Heart Rhythm Society (HRS) in San Diego, USA; the Global Cardiovascular Clinical Trialists Forum in Washington, USA, and the VVIC2025 Vaccines, Virology and Immunology Conference in Geneva, Switzerland, alongside numerous other engagements across UK & Europe. In 2025, her expertise was further acknowledged through contributions to major cardiovascular publications, including a Cardiovascular Health report developed in collaboration with Mediaplanet UK & Ireland, highlighting advancements in cardiac care and public health.

In addition to her global speaking engagements, Trudie continues to serve on a wide range of national and international Boards and Committees, contributing to ongoing research initiatives and acting as an abstract reviewer for Heart Rhythm Society 2025 & ESC2025. Her continued involvement in research, publications, advocacy and policy-shaping activities reinforces her position as a globally respected patient advocate and leader within the field of cardiac arrhythmias.

In 2025, Arrhythmia Alliance’s Pace4Life (P4L) programme received international recognition through the presentation of an oral abstract at the Heart Rhythm Society (HRS) Scientific Sessions, one of the world’s leading cardiovascular and electrophysiology conferences. This provided an important opportunity to showcase the impact of the A-A Pace4Life initiative on a global stage, highlighting the programme’s work in sustainable pacemaker reuse and its contribution to improving access to life-saving treatment in underserved communities. Presenting at HRS reinforced the credibility and innovation of the programme, while helping to raise international awareness, encourage collaboration, and support future growth of this important initiative.

ARRHYTHMIA ALLIANCE

TRUSTEES REPORT (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

7.Staffing

We continue to work remotely which is proving to be successful and enables a wider area and identify qualified and experience staff for when we are recruiting. We also retain long-term staff who have been with us for over 10 years (some for up to 30 years long-service!) so have the experience and understanding to be able to train lessexperienced or newly recruited staff.

Summary

Arrhythmia Alliance is a global organisation working to improve diagnosis, treatment, and quality of life for people with heart rhythm disorders through collaboration between patients and healthcare professionals. In 2025, the charity focused on supporting patients through education, advocacy, resources, and awareness campaigns such as Know Your Pulse and Defibs Save Lives . World Heart Rhythm Week successfully raised global awareness, while partnerships strengthened its international reach.

The organisation continued to educate healthcare professionals through events like Heart Rhythm Updates and the Heart Rhythm Congress, which attracted over 2,000 delegates. Global initiatives such as A-A Pace4Life and Hearts of Ghana expanded access to treatment and training in underserved areas.

Fundraising increased, though grant funding remained challenging. Community support, volunteer engagement, and remote working continued to strengthen the organisation’s impact.

Overall, Arrhythmia Alliance remains committed to improving outcomes for people living with arrhythmias through collaboration, education, and advocacy.

Total reach on social media: 312,943

Total subscribers on the online forum: 49,074

Database: approx. 125,000

Financial review

Balance Sheet

At the end of the year the Charity is in a strong position with funding in place from a variety of Foundations. The charity's total funds at the end of the period was £1,100,157.

The Trustees have a strategic and operational plan in place to ensure stability and growth.

Statements of financial activities

During the year income has decreased from £831,260 to £793,369. Expenses have decreased from £1,044,471 to £1,001,009; the majority of costs relate to the running of the Congress. The principal sources of funds are gained from Grants and Donations.

Reserves policy

The Trustees have a policy of maintaining a level of unrestricted reserves which should ensure that there are adequate funds to meet anticipated future liabilities. In practice the Trustees consider that holding reserves equivalent to a minimum of three months' core costs (i.e the day to day running costs of the Charity), excluding funds tied up in fixed assets, should provide sufficient funds to respond to unexpected adverse changes in the Charity's funding or activities. This equates to a minimum of £32,000 based on current levels of activity. The Trustees intend to gradually build up unrestricted reserves to the desired level over the next few years.

ARRHYTHMIA ALLIANCE

TRUSTEES REPORT (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

Structure, governance and management

Governing document

The charity is constituted under a Trust deed dated 30 November 2004 and is registered charity number 1107496. The charity was granted charitable status on 7 January 2005.

Appointment of trustees

The management of the charity is the responsibility of the Trustees who are elected and co-opted under the terms of the Trust deed.

There must at all times be a minimum of three Trustees. The first Trustees are entitled to hold office for life. Future Trustees must be appointed by a resolution of the Trustees.

Organisation

An Executive Committee compromising of 20 members supports the Trustees and as of 1 January 2008, the Chief Executive is responsible for managing and controlling the activities of the Charity under the Trustees direction.

Trustee Induction and training

New Trustees undergo an orientation process to brief them on their legal obligations under Charity Law, the Charity's governing documents, the Committee and decision-making processes, the Business Plan and recent financial performance of the Charity. During the induction process they meet key employees and other Trustees. Trustees are encouraged to attend appropriate external and internal training events, which will assist them in carrying out their role.

Key management remuneration

The Founder & CEO is not remunerated as she is a Trustee. Pay and remuneration for key management personnel is set in accordance with guidelines for the roles they fulfil within the Third Sector.

Risk management

Risks considered are Health & Safety; Display Screen Equipment; GDPR; Policy for Safeguarding vulnerable adults and children etc.

All risks are managed with professional advise received from Citation (HR appointed company) and adjustments made as required from advice received. Citation (HR Company) also provide HR advice, staff contracts and policy handbooks; IT and Web Consultants provide support within these areas.

The Medical Advisory Board review and approve charity literature.

One of the Trustees is an accountant and assists and provides financial guidance; we also have a lawyer to provide legal advice to cover any such risk.

ARRHYTHMIA ALLIANCE

TRUSTEES REPORT (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

The Trustees who served during the year and up to the date of signature of the financial statements were: Mrs T C A Lobban MBE

Mr N Breakwell Professor N J Linker Prof. A J Camm Mr P Turner Mr P Chauvineau Mr M Bullock Dr A J Turley Professor. J Morgan

(Appointed 12 August 2025)

Acknowledgements

Arrhythmia Alliance would like to acknowledge the various Trusts, Foundations and Medical Industry that so generously gave their support during the financial year.

Connected Charities

As the parent organisation, Arrhythmia Alliance works in direct partnership with its affiliates - Atrial Fibrillation Association (AFA), AFA-US, Syncope Trust (STARS), STAR-US and Arrhythmia Alliance US.

Arrhythmia Alliance also works with Sudden Adult Death Syndrome (SADS UK), Cardiomyopathy Association (CMA), the Department of Health, the Heart Improvement Programme, the Primary Care Cardiovascular Society, the Royal College of Nursing, the National Service Framework Team and the Medical Technology Group. Also included are the Genetic Interest Group (GIG), Long-term Medical and Primary Care Trust. Industry partners include the Association of British Healthcare Industries - Cardiac Rhythm Management. All groups aim to work together to promote timely and effective diagnosis and treatment of arrhythmia.

The Trustees report was approved by the Board of Trustees.

Mrs T C A Lobban MBE

Trustee

21 October 2026

ARRHYTHMIA ALLIANCE

STATEMENT OF TRUSTEES RESPONSIBILITIES

FOR THE YEAR ENDED 31 DECEMBER 2025

The Trustees are responsible for preparing the Trustees Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

The law applicable to charities in England and Wales requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources of the charity for that year.

In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping sufficient accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the trust deed. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

ARRHYTHMIA ALLIANCE

INDEPENDENT AUDITOR'S REPORT

TO THE TRUSTEES OF ARRHYTHMIA ALLIANCE

Opinion

We have audited the financial statements of Arrhythmia Alliance (the ‘charity’) for the year ended 31 December 2025 which comprise the statement of financial activities, the balance sheet, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the Trustees use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charity’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the Trustees with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The Trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

ARRHYTHMIA ALLIANCE

INDEPENDENT AUDITOR'S REPORT (CONTINUED)

TO THE TRUSTEES OF ARRHYTHMIA ALLIANCE

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters in relation to which the Charities (Accounts and Reports) Regulations 2008 require us to report to you if, in our opinion:

Responsibilities of Trustees

As explained more fully in the statement of Trustees responsibilities, the Trustees are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the Trustees are responsible for assessing the charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustees either intend to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

We have been appointed as auditor under section 144 of the Charities Act 2011 and report in accordance with the Act and relevant regulations made or having effect thereunder.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

We gained an understanding of the legal and regulatory framework applicable to the company and the industry in which it operates, and considered the risk of acts by the company that were contrary to applicable laws and regulations, including fraud. We designed audit procedures to respond to the risk, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.

We focused on laws and regulations which could give rise to a material misstatement in the financial statements, including, but not limited to, the Companies Act 2006 and UK tax legislation. Our tests included agreeing the financial statement disclosures to underlying supporting documentation, enquiries with management and enquiries of legal counsel. There are inherent limitations in the audit procedures described above and, the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it. We did not identify any key audit matters relating to irregularities, including fraud. As in all our audits, we also addressed the risk of management override of internal controls, including testing journals and evaluating whether there was evidence of bias by the directors that represented a risk of material misstatement due to fraud.

ARRHYTHMIA ALLIANCE

INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE TRUSTEES OF ARRHYTHMIA ALLIANCE

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https:// www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Other matters

Your attention is drawn to the fact that the charity has prepared financial statements in accordance with "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (as amended) in preference to the Accounting and Reporting by Charities: Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extant regulations but has now been withdrawn.

This has been done in order for the financial statements to provide a true and fair view in accordance with current Generally Accepted Accounting Practice.

Use of our report

This report is made solely to the company’s members, as a body, in accordance with section 391 of the Companies Act 2014. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Philip Burton BSc FCA (Senior Statutory Auditor)

21 October 2026

For and on behalf of Bronsens Chartered Certified Accountants Statutory Auditor

Eden House Two Rivers Business Park Station Lane Witney Oxfordshire England OX28 4BL

Bronsens is eligible for appointment as auditor of the charity by virtue of its eligibility for appointment as auditor of a company under section 1212 of the Companies Act 2006.

ARRHYTHMIA ALLIANCE

STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 DECEMBER 2025

Unrestricted Unrestricted
funds funds
2025 2024
Notes £ £
Income from:
Donations and legacies 3 150,326 200,009
Charitable activities 4 625,573 600,766
Investments 5 17,470 30,485
Total income 793,369 831,260
Expenditure on:
Charitable activities 6 1,001,009 1,044,471
Total expenditure 1,001,009 1,044,471
Net expenditure and movement in funds (207,640) (213,211)
Reconciliation of funds:
Fund balances at 1 January 2025 1,307,797 1,521,008
Fund balances at 31 December 2025 1,100,157 1,307,797

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

ARRHYTHMIA ALLIANCE

BALANCE SHEET

AS AT 31 DECEMBER 2025

Notes
Fixed assets
Tangible assets
13
Current assets
Debtors
14
Cash at bank and in hand
Creditors: amounts falling due within one
year
15
Net current assets
Total assets less current liabilities
Net assets excluding pension liability
The funds of the charity
Unrestricted funds
2025
£
£
2,528
133,804
1,113,366
1,247,170
(149,541)
1,097,629
1,100,157
1,100,157
1,100,157
1,100,157
2024
£
£
5,582
88,916
1,365,406
1,454,322
(152,107)
1,302,215
1,307,797
1,307,797
1,307,797
1,307,797
2024
£
£
5,582
88,916
1,365,406
1,454,322
(152,107)
1,302,215
1,307,797
1,307,797
1,307,797
1,307,797
1,307,797
1,307,797
1,307,797
1,307,797

The financial statements were approved by the Trustees on 21 October 2026

Mrs T C A Lobban MBE

Trustee

ARRHYTHMIA ALLIANCE

STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 DECEMBER 2025

Notes
Cash flows from operating activities
Cash absorbed by operations
20
Investing activities
Purchase of tangible fixed assets
Investment income received
Net cash generated from investing activities
Net cash used in financing activities
Net decrease in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
2025
£
£
(269,218)
(292)
17,470
17,178
-
(252,040)
1,365,406
1,113,366
2024
£
£
(622,445)
(2,146)
30,485
28,339
-
(594,106)
1,959,512
1,365,406

ARRHYTHMIA ALLIANCE

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

1 Accounting policies

Charity information

Arrhythmia Alliance is a unincorporated charity.

1.1 Accounting convention

The financial statements have been prepared in accordance with the charity's [governing document], the Charities Act 2011, FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019). The charity is a Public Benefit Entity as defined by FRS 102.

The financial statements have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a true and fair view. This departure has involved following the Statement of Recommended Practice for charities applying FRS 102 rather than the version of the Statement of Recommended Practice which is referred to in the Regulations but which has since been withdrawn.

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2 Going concern

At the time of approving the financial statements, the Trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the Trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3 Charitable funds

Unrestricted funds are available for use at the discretion of the Trustees in furtherance of their charitable objectives.

Restricted funds are subject to specific conditions by donors or grantors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.

1.4 Income

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

FOR THE YEAR ENDED 31 DECEMBER 2025

ARRHYTHMIA ALLIANCE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

1 Accounting policies

(Continued)

Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset.

1.5 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably.

Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges are allocated on the portion of the asset’s use.

1.6 Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers

33% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.

1.7 Impairment of fixed assets

At each reporting end date, the charity reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

1.8 Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

FOR THE YEAR ENDED 31 DECEMBER 2025

ARRHYTHMIA ALLIANCE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

1 Accounting policies

(Continued)

1.9 Financial instruments

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the charity’s contractual obligations expire or are discharged or cancelled.

1.10 Employee benefits

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the charity is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.11 Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

ARRHYTHMIA ALLIANCE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

2 Critical accounting estimates and judgements

In the application of the charity’s accounting policies, the Trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3 Income from donations and legacies

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Donations 15,586 16,469
Grants 102,251 111,744
Other fundraising and sponsorships 32,489 71,796
150,326 200,009

4 Income from charitable activities

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Charitable activites
Grants received and other income 624,615 598,015
AED funds 958 2,751
625,573 600,766

ARRHYTHMIA ALLIANCE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

5 Income from investments

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Interest receivable 17,470 30,485

6 Expenditure on charitable activities

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Direct costs
Staff costs 223,996 223,022
Telephone 5,989 6,966
Printing, postage and stationery 30,183 28,317
Conferences and travel 486,784 546,304
AED equipment cost 4,057 6,119
Computer maintenance costs 12,327 10,726
Other direct costs 21,420 22,208
784,756 843,662
Share of support and governance costs (see note 7)
Support 214,353 198,909
Governance 1,900 1,900
1,001,009 1,044,471
Analysis by fund
Unrestricted funds 1,001,009 1,044,471

ARRHYTHMIA ALLIANCE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

7 Support costs allocated to activities

Staff costs
Depreciation
Fundraising costs
Other direct costs
Legal and professional fees
Computer and other costs
Computer and printer lease
Printing, postage, stationery and advertising
Rent, rates and insurance
Bank and finance charges
Contribution to AA USA
Consultancy costs
Governance costs
Analysed between:
Unrestricted funds
8
Net movement in funds
The net movement in funds is stated after charging/(crediting):
Fees payable for the audit of the charity's financial statements
Depreciation of owned tangible fixed assets
9
Auditor's remuneration
Fees payable to the charity's auditor and associates:
For audit services
Audit of the financial statements of the charity
2025
£
7,194
3,346
832
3,118
46,486
24,244
389
1,589
12,490
4,948
96,757
12,960
1,900
216,253
216,253
2025
£
1,900
3,345
2025
£
1,900
2024
£
7,220
5,205
696
3,629
42,838
27,242
316
1,490
10,041
4,947
82,325
12,960
1,900
200,809
200,809
2024
£
1,900
5,205
2024
£
1,900

ARRHYTHMIA ALLIANCE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

10 Trustees

There were no trustees' remuneration or other benefits for the year ended 31 December 2025 nor for the year ended 31 December 2024.

Trustees' expenses

During the year £630 (2024: £701) was reimbursed to 1 (2024:1) Trustees for travel costs incurred on behalf of the charity and other costs paid on behalf of the charity.

11 Employees

The average monthly number of employees during the year was:

Employment costs
Wages and salaries
Social security costs
Other pension costs
2025
Number
10
2025
£
212,413
14,389
4,388
231,190
2024
Number
10
2024
£
212,508
14,013
3,721
230,242

There were no employees whose annual remuneration was more than £60,000.

12 Taxation

The charity is exempt from taxation on its activities because all its income is applied for charitable purposes.

ARRHYTHMIA ALLIANCE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

13 Tangible fixed assets

Cost
At 1 January 2025
Additions
At 31 December 2025
Depreciation and impairment
At 1 January 2025
Depreciation charged in the year
At 31 December 2025
Carrying amount
At 31 December 2025
At 31 December 2024
14
Debtors
Amounts falling due within one year:
Other debtors
Prepayments and accrued income
15
Creditors: amounts falling due within one year
Other taxation and social security
Other creditors
2025
£
94,407
39,397
133,804
2025
£
5,794
143,747
149,541
Computers
£
210,595
292
210,887
205,014
3,345
208,359
2,528
5,582
2024
£
41,451
47,465
88,916
2024
£
5,998
146,109
152,107

ARRHYTHMIA ALLIANCE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

16 Retirement benefit schemes
2025 2024
Defined contribution schemes £ £
Charge to profit or loss in respect of defined contribution schemes 4,388 3,721

The charity operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the charity in an independently administered fund.

17 Unrestricted funds

The unrestricted funds of the charity comprise the unexpended balances of donations and grants which are not subject to specific conditions by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes.

At 1 January
2025
£
General funds
1,307,797
Previous year:
At 1 January
2024
£
General funds
1,521,008
Incoming
resources
Resources
expended
At 31
December
2025
£
£
£
793,369
(1,001,009)
1,100,157
Incoming
resources
Resources
expended
At 31
December
2024
£
£
£
831,260
(1,044,471)
1,307,797

18 Transactions with related parties

During the year, the charity recharged £5,550 (2024: £6,237) to Syncope Trust and Reflex Seizures (STARS), charity number 1084898 for costs incurred on their behalf. Repaying for services was apportioned to STARS for £42,601 (2024: £52,924). The balance due to this charity at the year end was £83,740 (2024: £46,689).

During the year, the charity recharged £5,550 (2024: £6,237) to Atrial Fibrillation Association (AFA), charity number 1122442 for costs incurred on their behalf. Salary costs totalling £56,302 (2024: £63,108) recharged from the charity to AFA. Repaying for services was apportioned to AFA for £39,355 (2024: £54,178). The balance due from this charity at the year end was £47,818 (2024: £25,560).

Repaying of services was apportioned to Arrhythmia Alliance US of £96,757 (2024: £82,325).

19 Related party transactions

There were no disclosable related party transactions during the year (2024 - none).

ARRHYTHMIA ALLIANCE

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2025

20
Cash generated from operations
Deficit for the year
Adjustments for:
Investment income recognised in statement of financial activities
Depreciation and impairment of tangible fixed assets
Movements in working capital:
(Increase)/decrease in debtors
(Decrease) in creditors
Cash absorbed by operations
21
Analysis of changes in net funds
At 1
Cash at bank and in hand
January 2025
£
1,365,406
1,365,406
1,365,406
2025
£
(207,640)
(17,470)
3,346
(44,888)
(2,566)
(269,218)
Cash flows
At
£
(252,040)
(252,040)
(252,040)
2024
£
(213,211)
(30,485)
5,205
17,986
(401,940)
(622,445)
31 December
2025
£
1,113,366
1,113,366
1,113,366